Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Waymade Australia is a pharmaceutical company specializing in the sourcing, marketing, and distribution of generic and branded medicines across the Australian healthcare sector. As a subsidiary of the global Waymade Group, the company leverages extensive international expertise to introduce high-quality therapeutic options to the local market. Their portfolio primarily features niche generic products and specialty pharmaceuticals designed to meet specific patient needs. Waymade Australia manages the entire product lifecycle from regulatory approval through the Therapeutic Goods Administration (TGA) to commercial distribution. The company is committed to providing cost-effective healthcare solutions while maintaining rigorous quality and compliance standards. Through strategic partnerships and a robust supply chain, Waymade Australia supports healthcare providers in delivering essential treatments to patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Waymade Australia.